Jeito Capital Leads €132M Series to Advance Phase 3 Trials for Rare Neuro-Metabolic Disorders
Jeito Capital said it is leading a €132 million oversubscribed Series B funding round in Azafaros, a clinical-stage biotech company developing treatments for rare lysosomal storage disorders.
Azafaros, founded in 2018 and rooted in Dutch academic research, is advancing nizubaglustat, a first-in-class dual-acting drug targeting conditions like Niemann-Pick Type C and GM1/GM2 gangliosidoses, they said.
'Azafaros has the potential to develop new efficient, safe and tolerable therapeutic options for young patients suffering from progressive debilitating and even fatal rare metabolic disorders that generates very high expectations.' said Dr Rafaèle Tordjman, Founder and CEO of Jeito Capital. 'We look forward to supporting the talented Azafaros team with our collective expertise to accelerate its pivotal clinical developments to go faster to patients.'
Contact:
Exec Edge
Editor@executives-edge.com
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Bloomberg
3 hours ago
- Bloomberg
Samsung-Backed Chipmaker Axelera AI Looks to Raise €150 Million
Axelera AI, a startup chipmaker backed by Samsung Electronics Co. and the European Union, is in talks to raise more than €150 million ($175 million) in financing as the continent aims to strengthen its high-performance computing capacity. The Dutch company is speaking to existing and new investors, with plans to close the funding round by the year's end, according to people familiar with the matter. They asked not to be identified citing private plans, which they said could change. It's not clear what valuation the new funding would yield.
Bloomberg
4 hours ago
- Bloomberg
Dutch Energy Firm TenneT Attracts Investor Interest After Debt Guarantee
MUFG Securities executed over $500 million of trades in TenneT Holding BV 's bonds in July, marking a flurry of interest in the Dutch electricity firm after the government approved a debt guarantee. 'We see strong scope for TenneT bonds to outperform,' said Chris Orr, head of credit trading for MUFG's Europe, Middle East and Africa division. He added that there's potential for the debt to trade at a tighter spread premium compared with AAA-rated sovereign, supranational and agency debt lacking a state guarantee.
Wall Street Journal
10 hours ago
- Wall Street Journal
Aegon Raises Shareholder Payout After Operating Profit Increase
Aegon AGN -0.19%decrease; red down pointing triangle said it would increase its buyback program and interim dividend after posting higher first-half operating profit and better-than-expected cash generation on strong commercial momentum. The Dutch insurance and asset-management company said Thursday that operating profit for the half year rose 19% to 845 million euros ($984.5 million) compared with the prior year's period.
